In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver disease in industrialized countries. NAFLD has ...

This article will briefly discuss prevalence studies and the pathophysiology of NAFLD and focus on current discussions related to the specific lesions in the pathology of NASH, including the ...

One of these is non-alcoholic steatohepatitis, or NASH, the fatty liver disease that affects millions of people and which is poised to be one of pharma’s next big growth areas. Novartis ramped ...

“When you’re eating all these highly processed, high fat, high sugar foods, insulin goes into overdrive, which creates insulin resistance, then excess blood sugar, and then fatty liver ...

Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a ...

With the closing date for handicap entries at the Cheltenham Festival fast approaching, Billy Nash takes a look at some of the Irish novices that have recently met the qualifying criteria.

Feb 7 | Jelly Roll's Goodnight Nashville is now open on Lower Broadway. Take a look inside. Feb 7 | Veteran developer H.G. Hill Realty sold a Belle Meade property which it owned for nearly a ...

univr.it Non-alcoholic fatty liver disease (NAFLD) is a public health problem, affecting up to a third of the world’s adult population. Several cohort studies have consistently documented that NAFLD ...